{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T12:29:00Z","timestamp":1792326540097,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018734","name":"Joint United Nations Programme on HIV\/AIDS","doi-asserted-by":"publisher","award":["contract of PR No: 2022\/1236445 PO No: 202859205."],"award-info":[{"award-number":["contract of PR No: 2022\/1236445 PO No: 202859205."]}],"id":[{"id":"10.13039\/501100018734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10461-025-04890-w","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:35:36Z","timestamp":1763019336000},"page":"1063-1078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["HIV Pre-Exposure Prophylaxis Service Cascade and Risk Factors Associated with Loss to Follow-Up Among Key Populations in Indonesia: Data from a Real-World Pilot Implementation 2021\u20132023"],"prefix":"10.1007","volume":"30","author":[{"given":"Rudi","family":"Wisaksana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9648-5115","authenticated-orcid":false,"given":"Nadia","family":"Hanum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miasari","family":"Handayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mawar N.","family":"Pohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarinanda A.","family":"Putri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fani F.","family":"Rakhmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulfan","family":"Zazuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusnandar","family":"Anggadiredja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armina","family":"Padmasawitri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwi S.","family":"Anggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhalina","family":"Afriana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endang","family":"Lukitosari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagus R.","family":"Prabowo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"4890_CR1","unstructured":"UNAIDS. UNAIDS DATA. 2023.\u00a0https:\/\/www.unaids.org\/en\/resources\/documents\/2023\/2023_unaids_data. Accessed 22 July 2025."},{"key":"4890_CR2","volume-title":"Executive report on the development of HIV AIDS and sexually transmitted infections for the second quarter of 2023","author":"The Directorate of Prevention and Control of Infectious Diseases","year":"2023","unstructured":"The Directorate of Prevention and Control of Infectious Diseases. Executive report on the development of HIV AIDS and sexually transmitted infections for the second quarter of 2023. South Jakarta: Ministry of Health of the Republic of Indonesia; 2023."},{"issue":"1S","key":"4890_CR3","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1097\/QAI.0000000000003319","volume":"95","author":"T Brown","year":"2024","unstructured":"Brown T, et al. The AIDS epidemic model 2023 for estimating HIV trends and transmission dynamics in Asian epidemic settings. J Acquir Immune Defic Syndr. 2024;95(1S):e13\u201323.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"27","key":"4890_CR4","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u201399.","journal-title":"N Engl J Med"},{"issue":"5","key":"4890_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"issue":"22","key":"4890_CR6","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1001\/jama.2019.2591","volume":"321","author":"R Chou","year":"2019","unstructured":"Chou R, et al. Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US preventive services task force. JAMA. 2019;321(22):2214\u201330. https:\/\/doi.org\/10.1001\/jama.2019.2591.","journal-title":"JAMA"},{"issue":"7","key":"4890_CR7","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1016\/S2468-2667(21)00112-2","volume":"6","author":"BR Bavinton","year":"2021","unstructured":"Bavinton BR, Grulich AE. HIV pre-exposure prophylaxis: scaling up for impact now and in the future. Lancet Public Health. 2021;6(7):e528-33.","journal-title":"Lancet Public Health"},{"issue":"1","key":"4890_CR8","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/S2352-3018(18)30327-8","volume":"6","author":"R Schaefer","year":"2019","unstructured":"Schaefer R, et al. HIV prevention cascades: A unifying framework to replicate the successes of treatment cascades. Lancet HIV. 2019;6(1):e60\u20136.","journal-title":"Lancet HIV"},{"issue":"7","key":"4890_CR9","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1016\/S2352-3018(16)30062-5","volume":"3","author":"P Godfrey-Faussett","year":"2016","unstructured":"Godfrey-Faussett P. The HIV prevention cascade: more smoke than thunder? Lancet HIV. 2016;3(7):e286\u20138.","journal-title":"Lancet HIV"},{"issue":"2","key":"4890_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10461-022-03782-7","volume":"27","author":"N Thongsak","year":"2023","unstructured":"Thongsak N, et al. Risk factors associated with loss to follow-up among transgender women receiving HIV pre-exposure prophylaxis in Chiang Mai province, Thailand. AIDS Behav. 2023;27(2):473\u201383.","journal-title":"AIDS Behav"},{"issue":"11","key":"4890_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/OLQ.0000000000000514","volume":"43","author":"PA Chan","year":"2016","unstructured":"Chan PA, et al. Implementation of preexposure prophylaxis for human immunodeficiency virus prevention among men who have sex with men at a new England sexually transmitted diseases clinic. Sex Transm Dis. 2016;43(11):717\u201323.","journal-title":"Sex Transm Dis"},{"issue":"1","key":"4890_CR12","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.19.1.20903","volume":"19","author":"PA Chan","year":"2016","unstructured":"Chan PA, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. J Int AIDS Soc. 2016;19(1):20903.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"4890_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz101","volume":"6","author":"MA Spinelli","year":"2019","unstructured":"Spinelli MA, et al. Missed visits associated with future preexposure prophylaxis (PrEP) discontinuation among PrEP users in a municipal primary care health network. Open Forum Infect Dis. 2019;6(4):ofz101.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"4890_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/QAI.0000000000001724","volume":"79","author":"S Doblecki-Lewis","year":"2018","unstructured":"Doblecki-Lewis S, et al. Patterns and correlates of participant retention in a multi-city pre-exposure prophylaxis demonstration project. J Acquir Immune Defic Syndr. 2018;79(1):62\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"4890_CR15","doi-asserted-by":"publisher","first-page":"e028768","DOI":"10.1136\/bmjopen-2018-028768","volume":"9","author":"ZR Greenwald","year":"2019","unstructured":"Greenwald ZR, et al. Cohort profile: l\u2019actuel pre-exposure prophylaxis (PrEP) cohort study in Montreal, Canada. BMJ Open. 2019;9(6):e028768.","journal-title":"BMJ Open"},{"issue":"10","key":"4890_CR16","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1007\/s10461-019-02493-w","volume":"23","author":"CL Shover","year":"2019","unstructured":"Shover CL, et al. Mind the gaps: prescription coverage and HIV incidence among patients receiving pre-exposure prophylaxis from a large federally qualified health center in Los Angeles, California. AIDS Behav. 2019;23(10):2730\u201340.","journal-title":"AIDS Behav"},{"issue":"10","key":"4890_CR17","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1016\/S2352-3018(20)30203-4","volume":"7","author":"SE Rutstein","year":"2020","unstructured":"Rutstein SE, et al. Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies. Lancet HIV. 2020;7(10):e721\u201330.","journal-title":"Lancet HIV"},{"issue":"5","key":"4890_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/QAI.0000000000001129","volume":"73","author":"JL Marcus","year":"2016","unstructured":"Marcus JL, et al. Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation. J Acquir Immune Defic Syndr. 2016;73(5):540\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"4890_CR19","doi-asserted-by":"publisher","first-page":"e475","DOI":"10.1016\/S2352-3018(18)30130-9","volume":"5","author":"SA Golub","year":"2018","unstructured":"Golub SA, Enemchukwu CU. The critical importance of retention in HIV prevention. Lancet HIV. 2018;5(9):e475\u20136.","journal-title":"Lancet HIV"},{"issue":"11","key":"4890_CR20","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1007\/s10461-018-2125-2","volume":"22","author":"E Morgan","year":"2018","unstructured":"Morgan E, Ryan DT, Newcomb ME, Mustanski B. High rate of discontinuation may diminish PrEP coverage among young men who have sex with men. AIDS Behav. 2018;22(11):3645\u20138.","journal-title":"AIDS Behav"},{"issue":"2","key":"4890_CR21","doi-asserted-by":"publisher","first-page":"e25250","DOI":"10.1002\/jia2.25250","volume":"22","author":"D Krakower","year":"2019","unstructured":"Krakower D, et al. Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care. J Int AIDS Soc. 2019;22(2):e25250.","journal-title":"J Int AIDS Soc"},{"issue":"14","key":"4890_CR22","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1177\/0956462419879618","volume":"30","author":"E Cochrane","year":"2019","unstructured":"Cochrane E, Knapper C. Audit of patient retention in pre-exposure prophylaxis (PrEP) services in an integrated sexual reproductive health service setting. Int J STD AIDS. 2019;30(14):1432\u20135.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"4890_CR23","doi-asserted-by":"publisher","first-page":"e0244226","DOI":"10.1371\/journal.pone.0244226","volume":"16","author":"M Kimani","year":"2021","unstructured":"Kimani M, et al. I wish to remain HIV negative: Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya. PLoS ONE. 2021;16(1):e0244226.","journal-title":"PLoS ONE"},{"issue":"4","key":"4890_CR24","doi-asserted-by":"publisher","first-page":"e0228620","DOI":"10.1371\/journal.pone.0228620","volume":"15","author":"D Pillay","year":"2020","unstructured":"Pillay D, et al. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa. PLoS ONE. 2020;15(4):e0228620.","journal-title":"PLoS ONE"},{"key":"4890_CR25","unstructured":"UNAIDS. Successfully expanding the rollout of PrEP in Indonesia. 2022.\u00a0https:\/\/www.unaids.org\/en\/resources\/presscentre\/featurestories\/2022\/september\/20220901_prepindonesia#:~:text=PrEP%20was%20rolled%20out%20in,who%20have%20sex%20with%20men. Accessed 22 July 2025."},{"key":"4890_CR26","doi-asserted-by":"publisher","first-page":"100573","DOI":"10.1016\/j.ijregi.2025.100573","volume":"14","author":"N Hanum","year":"2025","unstructured":"Hanum N, et al. HIV Incidence and adherence following pre-exposure prophylaxis initiation among key populations in Indonesia: findings from a real-world pilot program 2021\u20132023. IJID Reg. 2025;14:100573.","journal-title":"IJID Reg"},{"key":"4890_CR27","unstructured":"Indonesian Ministry of Health. Guidelines for oral pre-expose prophylaxis (PrEP) program for people at high-risk of HIV infection in Indonesia. 2023.\u00a0https:\/\/www.who.int\/indonesia\/news\/publications\/other-documents\/guidelines-for-oral-pre-expose-prophylaxis-(prep)-program-for-people-at-high-risk-of-hiv-infection-in-indonesia. Accessed 22 July 2025."},{"issue":"12","key":"4890_CR28","doi-asserted-by":"publisher","first-page":"e26196","DOI":"10.1002\/jia2.26196","volume":"26","author":"FR Anam","year":"2023","unstructured":"Anam FR, et al. Let us lead: community leadership in the AIDS response is its fundamental pillar for success. J Int AIDS Soc. 2023;26(12):e26196.","journal-title":"J Int AIDS Soc"},{"key":"4890_CR29","volume-title":"What\u2019s the 2\u2009+\u20091\u2009+\u20091? event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: update to WHO\u2019s recommendation on oral PrEP","author":"WHO","year":"2019","unstructured":"WHO. What\u2019s the 2\u2009+\u20091\u2009+\u20091? event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: update to WHO\u2019s recommendation on oral PrEP. Geneva: World Health Organization; 2019."},{"key":"4890_CR30","unstructured":"Indonesian Ministry of Health. Guidelines for implementing HIV counseling and testing. 2014.\u00a0https:\/\/platform.who.int\/docs\/default-source\/mca-documents\/policy-documents\/law\/IDN-RH-43-07-LAW-2014-ind-MoH-Regulation-74-2014---Guideline-of-HIV-Counseling-and-Test-Implementation.pdf. Accessed 22 July 2025."},{"key":"4890_CR31","unstructured":"UNAIDS. Creating HIV prevention cascades-operational guidance on a tool for monitoring programmes. 2021.\u00a0https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/20211125_creating-hiv-prevention-cascades. Accessed 22 July 2025."},{"issue":"3","key":"4890_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/QAI.0000000000001251","volume":"74","author":"JT Parsons","year":"2017","unstructured":"Parsons JT, et al. Uptake of HIV Pre-Exposure prophylaxis (PrEP) in a National cohort of gay and bisexual men in the united States. J Acquir Immune Defic Syndr. 2017;74(3):285\u201392.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 3","key":"4890_CR33","doi-asserted-by":"publisher","first-page":"e25537","DOI":"10.1002\/jia2.25537","volume":"23","author":"D Were","year":"2020","unstructured":"Were D, et al. Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in kenya: results from a programmatic surveillance study. J Int AIDS Soc. 2020;23(Suppl 3):e25537.","journal-title":"J Int AIDS Soc"},{"issue":"Suppl 3","key":"4890_CR34","doi-asserted-by":"publisher","first-page":"e25540","DOI":"10.1002\/jia2.25540","volume":"23","author":"RA Ramautarsing","year":"2020","unstructured":"Ramautarsing RA, et al. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in thailand: learning through the HIV prevention cascade lens. J Int AIDS Soc. 2020;23(Suppl 3):e25540.","journal-title":"J Int AIDS Soc"},{"key":"4890_CR35","doi-asserted-by":"publisher","first-page":"108477","DOI":"10.1016\/j.drugalcdep.2020.108477","volume":"219","author":"Z Ni","year":"2021","unstructured":"Ni Z, et al. Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment. Drug Alcohol Depend. 2021;219:108477.","journal-title":"Drug Alcohol Depend"},{"key":"4890_CR36","first-page":"1000288","volume":"13","author":"T Verinumbe","year":"2024","unstructured":"Verinumbe T, et al. Associations of HIV pre-exposure prophylaxis (Prep) Indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD. Drug Alcohol Depend Report. 2024;13:1000288.","journal-title":"Drug Alcohol Depend Report"},{"issue":"4","key":"4890_CR37","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1007\/s10461-021-03488-2","volume":"26","author":"SM Walters","year":"2022","unstructured":"Walters SM, et al. PrEP care continuum engagement among persons who inject drugs: rural and urban differences in stigma and social infrastructure. AIDS Behav. 2022;26(4):1308\u201320.","journal-title":"AIDS Behav"},{"issue":"7","key":"4890_CR38","doi-asserted-by":"publisher","first-page":"e2221346","DOI":"10.1001\/jamanetworkopen.2022.21346","volume":"5","author":"CG Streed Jr","year":"2022","unstructured":"Streed CG Jr, et al. Prevalence of HIV preexposure prophylaxis prescribing among persons with commercial insurance and likely injection drug use. JAMA Netw Open. 2022;5(7):e2221346.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"4890_CR39","doi-asserted-by":"publisher","first-page":"e0002524","DOI":"10.1371\/journal.pgph.0002524","volume":"3","author":"S Mubezi","year":"2023","unstructured":"Mubezi S, et al. Factors associated with retention on pre-exposure prophylaxis among female sex workers in Kigali, Rwanda. PLOS Glob Public Health. 2023;3(11):e0002524.","journal-title":"PLOS Glob Public Health"},{"issue":"1","key":"4890_CR40","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/S2352-3018(19)30335-2","volume":"7","author":"J Kinuthia","year":"2020","unstructured":"Kinuthia J, et al. PrEP implementation for young women and adolescents (PrIYA) programme. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in kenya: results from an implementation programme. Lancet HIV. 2020;7(1):e38\u201348.","journal-title":"Lancet HIV"},{"issue":"4","key":"4890_CR41","doi-asserted-by":"publisher","first-page":"e076545","DOI":"10.1136\/bmjopen-2023-076545","volume":"14","author":"R Mpirirwe","year":"2024","unstructured":"Mpirirwe R, et al. HIV pre-exposure prophylaxis uptake, retention and adherence among female sex workers in sub-Saharan Africa: a systematic review. BMJ Open. 2024;14(4):e076545.","journal-title":"BMJ Open"},{"issue":"Suppl 4","key":"4890_CR42","doi-asserted-by":"publisher","first-page":"e25298","DOI":"10.1002\/jia2.25298","volume":"22","author":"CL Celum","year":"2019","unstructured":"Celum CL, et al. HIV pre-exposure prophylaxis for adolescent girls and young women in africa: from efficacy trials to delivery. J Int AIDS Soc. 2019;22(Suppl 4):e25298.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"4890_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12889-020-8195-x","volume":"20","author":"G Emmanuel","year":"2020","unstructured":"Emmanuel G, et al. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria. BMC Public Health. 2020;20(1):69.","journal-title":"BMC Public Health"},{"issue":"7","key":"4890_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/apc.2021.0074","volume":"35","author":"J Tao","year":"2021","unstructured":"Tao J, et al. Loss to Follow-Up and Re-Engagement in HIV Pre-Exposure prophylaxis care in the united States, 2013\u20132019. AIDS Patient Care STDS. 2021;35(7):271\u20137.","journal-title":"AIDS Patient Care STDS"},{"key":"4890_CR45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/cid\/ciy160","volume":"67","author":"LK Rusie","year":"2018","unstructured":"Rusie LK, et al. Preexposure prophylaxis initiation and retention in care over 5 years, 2012\u20132017: are quarterly visits too much? Clin Infect Dis. 2018;67:283\u20137.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4890_CR46","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/S2352-3018(18)30008-0","volume":"5","author":"B Grinsztejn","year":"2018","unstructured":"Grinsztejn B, et al. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP brasil: 48 week results of a demonstration study. Lancet HIV. 2018;5(3):e136\u201345.","journal-title":"Lancet HIV"},{"issue":"11","key":"4890_CR47","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1016\/S2352-3018(18)30215-7","volume":"5","author":"AE Grulich","year":"2018","unstructured":"Grulich AE, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11):e629\u201337.","journal-title":"Lancet HIV"},{"issue":"4","key":"4890_CR48","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/S2352-3018(22)00030-3","volume":"9","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis. Lancet HIV. 2022;9(4):e254\u201368.","journal-title":"Lancet HIV"},{"issue":"11","key":"4890_CR49","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3390\/v14112380","volume":"14","author":"A Eubanks","year":"2022","unstructured":"Eubanks A, et al. Loss to follow-up from HIV pre-exposure prophylaxis care in men who have sex with men in West Africa. Viruses. 2022;14(11):2380.","journal-title":"Viruses"},{"issue":"3","key":"4890_CR50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/cid\/ciaa037","volume":"72","author":"YA Huang","year":"2021","unstructured":"Huang YA, et al. Persistence with human immunodeficiency virus Pre-exposure prophylaxis in the united States, 2012\u20132017. Clin Infect Dis. 2021;72(3):379\u201385.","journal-title":"Clin Infect Dis"},{"key":"4890_CR51","volume-title":"Briefs on young key populations","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Briefs on young key populations. Geneva: World Health Organization; 2016."},{"issue":"2","key":"4890_CR52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/QAI.0000000000003474","volume":"97","author":"I Yigit","year":"2024","unstructured":"Yigit I, et al. Associations between PrEP stigma, PrEP Confidence, and PrEP adherence: conditional indirect effects of anticipated HIV stigma. J Acquir Immune Defic Syndr. 2024;97(2):99\u2013106.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"4890_CR53","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1016\/S2352-3018(23)00079-6","volume":"10","author":"JE Haberer","year":"2023","unstructured":"Haberer JE, et al. The future of HIV pre-exposure prophylaxis adherence: reducing barriers and increasing opportunities. Lancet HIV. 2023;10(6):e404\u201311.","journal-title":"Lancet HIV"},{"issue":"7","key":"4890_CR54","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1016\/S2352-3018(21)00005-9","volume":"8","author":"C Laurent","year":"2021","unstructured":"Laurent C, et al. HIV pre-exposure prophylaxis for men who have sex with men in West africa: a multicountry demonstration study. Lancet HIV. 2021;8(7):e420\u20138.","journal-title":"Lancet HIV"},{"key":"4890_CR55","doi-asserted-by":"publisher","first-page":"100541","DOI":"10.1016\/j.eclinm.2020.100541","volume":"26","author":"EW Wahome","year":"2020","unstructured":"Wahome EW, et al. PrEP uptake and adherence in relation to HIV-1 incidence among Kenyan men who have sex with men. EClinicalMedicine. 2020;26:100541.","journal-title":"EClinicalMedicine"},{"key":"4890_CR56","first-page":"100650","volume":"29\u201330","author":"L Coyer","year":"2020","unstructured":"Coyer L, et al. Understanding pre-exposure prophylaxis (PrEP) regimen use: switching and discontinuing daily and event-driven PrEP among men who have sex with men. EClinMed. 2020;29\u201330:100650.","journal-title":"EClinMed"},{"issue":"6","key":"4890_CR57","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/09540120310001618603","volume":"15","author":"S Agha","year":"2003","unstructured":"Agha S. The impact of a mass media campaign on personal risk perception, perceived self-efficacy and on other behavioural predictors. AIDS Care. 2003;15(6):749\u201362.","journal-title":"AIDS Care"},{"issue":"Suppl 5","key":"4890_CR58","doi-asserted-by":"publisher","first-page":"e25130","DOI":"10.1002\/jia2.25130","volume":"21","author":"G Ayala","year":"2018","unstructured":"Ayala G, et al. Blue-Ribbon boys: factors associated with PrEP use, ART use and undetectable viral load among gay app users across six regions of the world. J Int AIDS Soc. 2018;21(Suppl 5):e25130.","journal-title":"J Int AIDS Soc"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04890-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04890-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04890-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:09:30Z","timestamp":1776071370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04890-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4890"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04890-w","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"12 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research protocol was reviewed and all versions of the study documents (information sheet, consent form, and questionnaires) were approved by the designated research ethics committee (Padjajaran University Research Ethics Committee IRB no. 655\/UN6.KEP\/EC\/2024) to implement, monitor and evaluate the program at the participating healthcare facilities.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All participants provided written informed consent before the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}